Established in 1992 by scientists experienced in high throughput DNA sequencing, human genomics, and genetic analysis research, Retrogen, Inc. is a trusted provider of quality genomic products and services. Our mission is to develop and commercialize quality genomic services for studying gene function and analyzing genetic disease in the post-genomics era.
At Retrogen we use the most advanced technologies to offer our clients a suite of genomic service solutions that accelerate novel research in elucidating gene function. Our commitment to build a world-class operation with state-of-the-art instrumentation and proprietary protocols allows us to quickly and securely deliver the highest quality results to our clients. With efficient delivery of quality results our clients can accomplish their projects goals faster, with flexible scalability to avoid the unnecessary expense of redundant protocols. In addition, our reputation is built on a solid, twenty-year track record of quality and expertise that has made us a leading provider in the field of genomic services. All work done at Retrogen, Inc. is performed using Good Laboratory Practices (GLP) as specified by FDA.